VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA

VitaDAO
  • 5.0 (1)
  • TECNOLOGÍA
  • CADA DOS SEMANAS
VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA

Our core mission is the acceleration of research and development (R&D) in the longevity space and the extension of human life and healthspan. To achieve this, VitaDAO collectively funds and digitizes research in the form of IP-NFTs. 👉vitadao.com

  1. The Mouse Longevity Chronicles: Unraveling Aging with Dr. Richard Miller during The Aging Science podcast by VitaDAO

    21/03/2023

    The Mouse Longevity Chronicles: Unraveling Aging with Dr. Richard Miller during The Aging Science podcast by VitaDAO

    In this podcast, I (@aging_scientist) spoke with Dr. Rich Miller about the ins and outs of mouse aging. The topics we discussed, roughly in this order, included the Interventions Testing Program, rapamycin, mecilizine, and other lifespan-extending drugs. We talked about the importance of genetically heterogenous mouse stocks and the issues with fast-aging progeroid mouse models. We also covered his more recent work on aging rate indicators and the difference between classic biomarkers and aging rate indicators. Finally, we talked about the importance of lifespan research, misuse of the word healthspan, and the emerging use of frailty indices in mice. VitaDAO and Kamil Pabis, MSc (the @Aging_Scientist on Twitter) bring this podcast to you.

    1 h y 35 min
  2. Exploring the Frontiers of Science: Breakthroughs, Funding Challenges, and Replication Crisis with Alaattin Kaya during The Aging Science podcast by VitaDAO

    02/03/2023

    Exploring the Frontiers of Science: Breakthroughs, Funding Challenges, and Replication Crisis with Alaattin Kaya during The Aging Science podcast by VitaDAO

    Slowing aging by a couple of percents would save more money than curing any single disease, be it cancer, heart disease, or diabetes. Aging is, in fact, the major risk factor that all these diseases have in common. For this reason, slowing aging becomes the most efficient path to a sustainable and healthy future for humanity. To get this message out we started The Aging Science podcast. We will bring you interviews and frank conversations with leading experts in the field of longevity, as well as evidence-based health advice to support you on this journey. This podcast is brought to you by VitaDAO and Kamil Pabis, MSc (the @Aging_Scientist on Twitter). In this podcast, I (@aging_scientist) had the pleasure of interviewing Asst. Prof Alaattin Kaya (@akay_lab). We talked about recent breakthroughs in the field, the difficulties of getting funding for risky and novel research, funding agencies, “fishing expeditions”, the importance of overexpression genetic screens in aging research, novel mechanisms of action, and the replication crisis.

    1 h y 17 min

  3. 23/02/2023

    Insights on Grant-making and Systemic Change: Lessons from Impetus and Beyond

    Insights on Grant-making and Systemic Change: Lessons from Impetus and Beyond with  Martin Borch Jensen & Lada Nuzhna. Outline:  0:00 What is Impetus and how did it get started? 3:12 Takeaways from running and creating Impetus Grants 5:04 Playbook for starting a grant-making program. 12:29 Common misunderstandings between the private sector and academia about funding. 14:12 The role of academia in publishing negative results 23:18 The most impactful levers for systemic change.

    50 min

  4. 19/02/2023

    Studying the genetic make-up of long-lived individuals with Joris Deelen

    Dr Joris Deelen leader at the Max Planck for Biology of AGeing since 2020 and is passionate about research on human aging.

    31 min

  5. 19/02/2023

    DNA damage as a driver of cellular senescence and agingwith Prof. Matt Yousefzadeh

    Matt Yousefzadeh, Ph.D., is a postdoctoral fellow in the laboratory of Dr. Laura Niedernhofer, Director of the Institute for the Biology of Aging and Metabolism at the University of Minnesota. He is interested in the mechanisms by which endogenous DNA damage and cellular senescence drive aging.

    19 min

  6. 19/02/2023

    Fecal Microbiota Transplantation as an Immediate Healthspan Intervention with Dr. Jacques Mathieu

    Dr. Mathieu is a co-founder and the acting Chief Executive Officer of Sentinel Environmental where they are building better microbiomes. Co-founder of Advanced Microbiotics, a startup focused on developing therapeutics to combat antibiotic-resistant bacteria. Did his Ph.D. in environmental engineering at Rice University.

    31 min

  7. 16/02/2023

    The Longevity Prize: Undervalued Domains & Mechanism Design with Allison Duettmann

    Allison Duettmann is the president of Foresight Institute, a non-profit to advance biotech, nanotech, computing for the long-term benefit of life.

    32 min

  8. 16/02/2023

    Energy replacement: Harnessing the energy of light into mitochondrial chemical energy increase lifespan with Dr. Shahaf Peleg

    Dr. Shahaf Peleg is an Independent group leader, Metabolism and epigenetics in aging, FBN (Rostock)

    15 min
Ver todo (35)

Calificaciones y reseñas

Acerca de

Our core mission is the acceleration of research and development (R&D) in the longevity space and the extension of human life and healthspan. To achieve this, VitaDAO collectively funds and digitizes research in the form of IP-NFTs. 👉vitadao.com

Información

Para escuchar episodios explícitos, inicia sesión.

Mantente al día con este programa

Inicia sesión o regístrate para seguir programas, guardar episodios y enterarte de las últimas novedades.
Elige un país o región

Africa, Oriente Medio e India

Asia-Pacífico

Europa

Latinoamérica y el Caribe

Estados Unidos y Canadá